Evidence map›Paper›PMID 39896211›Full record

ArticleThe journal of allergy and clinical immunology. Global2025

Eosinophil ETosis and Charcot-Leyden crystals in Kimura disease.

Yuzaburo Inoue, Hitoshi Ogata, Yoshitake Sato, Daigo Kato, Kanako Mitsunaga, Mamiko Saito, Tatsuya Ishigaki, Minako Tomiita, Hiroshi Kuraishi, Keisuke Ito and 1 more

Abstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in The journal of allergy and clinical immunology. Global, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Yuzaburo InoueDepartment of General Medical Science, Graduate School of Medicine, Chiba University, Chiba, Japan.
Hitoshi OgataDepartment of Allergy and Rheumatology, Chiba Children's Hospital, Chiba, Japan.
Yoshitake SatoDepartment of Allergy and Rheumatology, Chiba Children's Hospital, Chiba, Japan.
Daigo KatoDepartment of Allergy and Rheumatology, Chiba Children's Hospital, Chiba, Japan.
Kanako MitsunagaDepartment of Allergy and Rheumatology, Chiba Children's Hospital, Chiba, Japan.
Mamiko SaitoDepartment of Ophthalmology, Chiba Children's Hospital, Chiba, Japan.
Tatsuya IshigakiDepartment of Plastic Surgery, Chiba Children's Hospital, Chiba, Japan.
Minako TomiitaDepartment of Allergy and Rheumatology, Chiba Children's Hospital, Chiba, Japan.
Hiroshi KuraishiDepartment of Pulmonology, Nagano Red Cross Hospital, Nagano, Japan.
Keisuke ItoDepartment of General Internal Medicine and Clinical Laboratory Medicine, Akita University Graduate School of Medicine, Akita, Japan.
Shigeharu UekiDepartment of General Internal Medicine and Clinical Laboratory Medicine, Akita University Graduate School of Medicine, Akita, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Two cases of refractory Kimura disease that required treatment with biologic agents are reported. Their pathology suggests the involvement of eosinophil ETosis, which is active cell death producing Charcot-Leyden crystals.

Indexed as

Charcot-Leyden crystaleosinophil ETosiseosinophilsKimura disease

Identifiers

PMID39896211
PMCPMC11783097

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.